Jump Financial, LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1831577 Chicago, IL

Position in FULC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,678,300

+$841,897 QoQ

Shares Held

1,005,000

+171.8% QoQ

Ownership

1.32%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#26

of 154 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. FULC ranks #39 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,678,300	1,005,000	+171.8%	Shares	Defined	2026-08-13
2026-03-31	$2,836,403	369,805	+301.1%	Shares	Defined	2026-05-14
2025-12-31	$1,042,782	92,200	+773.9%	Shares	Defined	2026-02-17
2025-03-31	$30,384	10,550	-88.8%	Shares	Defined	2025-05-14
2024-06-30	$583,922	94,181	+205.3%	Shares	Defined	2024-11-14
2024-03-31	$291,167	30,844	-66.4%	Shares	Sole	2024-05-13
2023-09-30	$407,547	91,790	+216.5%	Shares	Sole	2024-10-21
2022-06-30	$142,100	29,000	+166.5%	Shares	Sole	2022-08-09
2021-12-31	$192,502	10,882	-14.3%	Shares	Sole	2022-02-10
2021-06-30	$133,085	12,699	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.